Sea Mild Biotechnology , Ltd. Profit Margin

Sea Mild Biotechnology , Ltd. posts a profit margin of 3.8% as of June 2026. That compares with 4.56% in the prior-year period — down 16.6% year over year. That is below the sector sector average of 13.16%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Sea Mild Biotechnology , Ltd.'s profit margin was 4.56%. The latest reading is 3.8% — a 16.6% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

For its sector stocks, a profit margin near 13.16% is typical. Sea Mild Biotechnology , Ltd.'s 3.8% is lower that level. That is roughly 71.1% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Sea Mild Biotechnology , Ltd.'s profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 3.8% as of June 2026; use YoY and peer views to separate noise from signal.

Context for 7516.TWO's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 13.16%), and (3) consistency with growth and profitability. This page covers the first two; Sea Mild Biotechnology , Ltd.'s other metric pages and overview cover the third.